Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 22, 2012 | Cook launches peripheral drug-eluting stent in Australia | Regulatory Roundup | Cook launches 1st-of-its kind drug-eluting stent for PAD Cook Medical announced the Australian launch of its Zilver PTX drug-eluting peripheral stent, the 1st DES approved for patients with peripheral artery disease, according to the compan... |
| Mar 30, 2011 | Cleveland Clinic: Both hospital and startup incubator | $28 million may be just the beginning. That’s the return Cleveland Clinic received after the $78 million sale of Clinic spinoff Intelect Medical to Boston Scientific Corp. (NYSE:BSX). It was the largest of three exits so far for companies a... |
| Mar 29, 2011 | Cleveland Clinic’s most promising startups | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recov... |
| Oct 4, 2010 | Chris Coburn: Captain of the Cleveland Clinic Innovations crew | Coburn, the son of a thoracic surgeon, grew up eating politics and policy. He cut his commercialization teeth at Battelle, building the research institute’s Cleveland-based commercialization unit to 60 people. He has been executive director... |
| Sep 22, 2010 | Arterial Remodeling Technologies drums up $8.5 million for bioresorbable stents | Arterial Remodeling Technologies, a French company whose technology was developed in part by the Cleveland Clinic, has raised $8.5 million in venture capital funding to further develop its biodegradable stents. Fred Cornhill, former chairma... |
| Sep 22, 2010 | Cleveland Clinic spinoff raises $8.5M for biodegradable stents | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Sep 21, 2010 | Arterial Remodeling Technologies Raises $8.5M in Venture Financing | Arterial Remodeling Technologies, a Noisy le Roi, France-based developer of bioresorbable coronary polymer stents that are designed to promote the natural remodeling of an injured artery after angioplasty, has closed on a $8.5m new venture ... |
| Cleveland Clinic spinoff raises $8.5M for biodegradable stents | Arterial Remodeling Technologies, a French company whose technology was developed in part by the Cleveland Clinic, has raised $8.5 million in venture capital funding to further develop its biodegradable stents. Fred Cornhill, former chairma... | |
| Chris Coburn: Captain of the Cleveland Clinic Innovations crew | Chris Coburn is the captain of Cleveland Clinic Innovations, the corporate venturing arm of the Cleveland Clinic. The 53-year-old fitness enthusiast and his crew have an important job: nurturing inventions that emerge from several thousand ... |
Reviews 0
FAQ about Arterial Remodelling Technologies
How much funding has Arterial Remodelling Technologies raised?
Arterial Remodelling Technologies has raised $8.5M in total across 1 funding round.
What has the press written about Arterial Remodelling Technologies?
Parsers VC has collected 11 articles mentioning Arterial Remodelling Technologies, among them “Cook launches peripheral drug-eluting stent in Australia | Regulatory Roundup” (May 22, 2012) and “Cleveland Clinic: Both hospital and startup incubator” (Mar 30, 2011).
Is Arterial Remodelling Technologies still active?
Yes, Arterial Remodelling Technologies is active; its latest activity on Parsers VC dates from Mar 27, 2014.